Company* |
Company | Type/Product Area | Terms/Details (Date) |
CombiMatrix |
Intel Corp. |
Deal to study the feasibility of various projects using CombiMatrix's core technology |
Terms and details on the deal were not disclosed (9/8) |
CombiMatrix |
Furuno Electric Co. (Japan) |
Deal to design, engineer and build CombiMatrix's Bench-Top DNA Microarray Synthesizer for CustomArray microarrays |
CombiMatrix gets $1M up front and potential development and milestones payments; they will co-develop a commercial instrument (8/9) |
MWG Biotech |
Innovadyne Technologies Inc.* |
Collaboration to provide an integrated solution targeted to the protein crystallography market |
The product offering combines MWG's Theonyx lab automation robot system with the Innovadyne Nanodrop system; terms were not disclosed (7/13) |
SomaLogic Inc.* |
Undisclosed entity |
SomaLogic exclusively licensed technology to enhance the chemical diversity of aptamers |
The technology has been incorporated into the company's Selex process; details were not disclosed (7/21) |
Symyx |
UOP LLC |
Cross-licensing deal covering high-throughput research methodologies and equipment |
Symyx gets annual license fees and UOP would get payments from any Symyx sale of instruments covered by UOP patents (8/18) |
Symyx |
BP Petrochemicals |
They extended their collaboration focused on the discovery of catalysts to produce certain commodity chemicals |
The two-year deal signed in January 2003 was extended one year; BP has exclusive commercial rights and Symyx would get royalties on any resulting sales (7/19) |
Tm Bioscience |
LabOne Inc. |
Multiyear deal under which Tm will supply its Tag-It mutation detection tests |
LabOne is increasing its focus in the area of genetic testing; terms were not disclosed (7/19) |
Notes: | |||
* Private companies are indicated with an asterisk. | |||
Unless otherwise noted, the trading symbols listed for public companies are on the Nasdaq market. | |||
TSE = Toronto Stock Exchange. | |||
